NeOnc Noses Into Novel Brain Cancer Treatment
Treatment for brain cancer patients typically consists of surgery, radiation and an oral drug called Temozolomide, developed by Merck and now generic. The most serious cases, however, still have less than a three-month survival rate, Dr. Thomas Chen, …